Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02545478 · ClinicalTrials.gov registry record
Biomarkers in Infection
A clinical trial of Inflammation and Sepsis, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- 4,200
- Enrollment target
- 2
- Study locations
NCT02545478 is a study of Inflammation and Sepsis that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 4,200 participants, above the 256-participant average among 132 other Inflammation trials with a reported enrollment target (1541% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT02545478, a study of Inflammation and Sepsis, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- 4,200 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
Conditions Studied
Study Locations (2)
Massachusetts
- Massachusetts General Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,200 participants |
| Start Date | 2006-04 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02545478
The ClinicalTrials.gov registry entry for NCT02545478 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 256-participant average among 132 other Inflammation trials with a reported enrollment target (1541% higher). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Inflammation appearing as the primary indexed condition, and to 0 interventions.
NCT02545478 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02545478 about?
NCT02545478 is a clinical study titled "Biomarkers in Infection". The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
What is the current status of trial NCT02545478?
This trial is currently recruiting. The enrollment target is 4,200 participants. The study started on 2006-04. Estimated completion is 2028-12.
What conditions does trial NCT02545478 study?
This clinical trial studies the following conditions: Inflammation, Sepsis, Infection.
Who is sponsoring clinical trial NCT02545478?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02545478 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Reducing Frailty for Older Cancer Survivors Using Supplements II
RECRUITING · Phase 2
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.